National Recommendations for Pharmacoeconomic Evaluations Reporting for Reimbursement and Procurement of New Pharmaceutical Applications in Egypt by Mary Gamal, Amal Samir Sedrak, Gihan Hamdy Elsisi, Ahmed Elagamy, Ahmed Seyam, Mariam Eldebeiky, Randa Eldessoki

Get full text

Rare disease challenges and potential actions in the Middle East by Ahmad Nader Fasseeh, Nada Korra, Ahmed Aljedai, Ahmed Seyam, Hajer Almudaiheem, Hana A. Al-Abdulkarim, Marwan Janahi, Mary Gamal, Sahar Fahmy, Sara Aldallal, Sherif Abaza, Zoltán Kaló

Get full text

A multi-criteria decision analysis (MCDA) tool for purchasing off-patent oncology medicines in Egypt by Baher Elezbawy, Ahmad Nader Fasseeh, Amal Sedrak, Randa Eldessouki, Mary Gamal, Mariam Eldebeiky, Hanaa Amer, Shimaa Akeel, Ahmad Morsy, Amira Amin, Amr Shafik, Sherif Abaza, Zoltán Kaló

Get full text

Correction: Framework for developing cost-effectiveness analysis threshold: the case of Egypt by Ahmad N. Fasseeh, Nada Korra, Baher Elezbawy, Amal S. Sedrak, Mary Gamal, Randa Eldessouki, Mariam Eldebeiky, Mohsen George, Ahmed Seyam, Asmaa Abourawash, Ahmed Y. Khalifa, Mayada Shaheen, Sherif Abaza, Zoltán Kaló

Get full text

Framework for developing cost-effectiveness analysis threshold: the case of Egypt by Ahmad N. Fasseeh, Nada Korra, Baher Elezbawy, Amal S. Sedrak, Mary Gamal, Randa Eldessouki, Mariam Eldebeiky, Mohsen George, Ahmed Seyam, Asmaa Abourawash, Ahmed Y. Khalifa, Mayada Shaheen, Sherif Abaza, Zoltán Kaló

Get full text